iShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC) Stock Short Interest Falls 54.8%
by Mitch Edgeman · The Markets DailyiShares LifePath Target Date 2035 ETF (NYSEARCA:ITDC – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 10,242 shares, a drop of 54.8% from the August 31st total of 22,673 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average trading volume of 20,735 shares, the short-interest ratio is presently 0.5 days.
iShares LifePath Target Date 2035 ETF Trading Down 0.0%
Shares of NYSEARCA:ITDC traded down $0.01 during trading on Wednesday, reaching $36.42. 765 shares of the stock were exchanged, compared to its average volume of 22,062. iShares LifePath Target Date 2035 ETF has a 12 month low of $33.03 and a 12 month high of $37.56. The stock has a 50-day moving average price of $36.88 and a 200-day moving average price of $36.10. The firm has a market cap of $118.72 million, a PE ratio of 20.04 and a beta of 0.65.
iShares LifePath Target Date 2035 ETF Company Profile
The iShares LifePath Target Date 2035 ETF USD (ITDC) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2035 ITDC was launched on Oct 17, 2023 and is issued by BlackRock.
See Also
- Five stocks we like better than iShares LifePath Target Date 2035 ETF
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential